ChemoMetec

CHEMM.COPre-clinical

Allerød, DenmarkFounded 1997chemometec.com

Founded in 1997 and headquartered in Denmark, ChemoMetec designs and manufactures automated cell counters and cell analysers used globally in biotech, pharma, and academic research. Its core technology provides rapid, reproducible, and reliable cell counting, with instruments like the NucleoCounter® NC-202™ and XcytoMatic® 40 being 21 CFR Part 11/GMP-ready for integration into regulated workflows. The company is publicly listed on the Nasdaq Copenhagen exchange and is strategically positioned to capitalize on the growth of advanced therapies and bioprocessing.

Market Cap

$1.1B

Founded

1997

Focus

DiagnosticsCell Therapy

CHEMM.CO · Stock Price

USD 398.60404.90 (-50.39%)

Historical price data

AI Company Overview

Technology Platform

Proprietary platform for automated, image-based cell counting and analysis using single-use cassettes, designed for high precision, reproducibility, and seamless integration into GMP/21 CFR Part 11-compliant workflows.

Funding History

IPOUndisclosedUndisclosedJun 23, 2017

Opportunities

Significant growth is driven by the expansion of cell and gene therapy manufacturing, which requires GMP-compliant tools, and the broader trend towards automation and high-throughput processing in biopharma.

The company's focus on regulatory-ready, high-precision instruments positions it perfectly to capture market share in these high-value segments.

Risk Factors

Faces intense competition from larger, diversified life science tool companies.

Its growth is also tied to capital expenditure cycles in biotech and pharma, which can be sensitive to economic downturns.

Technological disruption from new cell analysis methods remains a constant threat.

Competitive Landscape

Competes with major players like Thermo Fisher Scientific and Bio-Rad, as well as specialists like Nexcelom Bioscience. ChemoMetec differentiates through a strong emphasis on GMP/21 CFR Part 11 compliance for manufacturing environments, proprietary cassette-based systems for reduced variability, and a focus on high-density and complex sample analysis.

Publications